Topbuild Corp buy BiotechBee
Start price
08.08.23
/
70%
€268.00
Target price
31.01.26
€330.00
Performance (%)
-12.69%
End price
01.10.23
€234.00
Summary
This prediction ended on 01.10.23 with a price of €234.00. The prediction for Topbuild Corp disappointed with a performance of -12.69%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Topbuild Corp | - | - | -16.162% | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
According to BiotechBee what are the pros and cons of Topbuild Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Topbuild Corp diskutieren
Buy mit Kursziel 330,0